The development of COVID-19 vaccines has buoyed the fortunes of several pharma and biotech companies this year. Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA), and Novavax…
The development of COVID-19 vaccines has buoyed the fortunes of several pharma and biotech companies this year. Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA), and Novavax…